KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Assets (2017 - 2026)

Cardlytics filings provide 10 years of Assets readings, the most recent being $263.9 million for Q1 2026.

  • Quarterly Assets fell 28.49% to $263.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $263.9 million through Mar 2026, down 28.49% year-over-year, with the annual reading at $285.6 million for FY2025, 27.26% down from the prior year.
  • Assets hit $263.9 million in Q1 2026 for Cardlytics, down from $285.6 million in the prior quarter.
  • Across five years, Assets topped out at $1.2 billion in Q1 2022 and bottomed at $263.9 million in Q1 2026.
  • Average Assets over 5 years is $592.5 million, with a median of $569.0 million recorded in 2024.
  • Peak annual rise in Assets hit 20.35% in 2022, while the deepest fall reached 45.3% in 2022.
  • Cardlytics' Assets stood at $691.2 million in 2022, then fell by 16.94% to $574.1 million in 2023, then crashed by 31.6% to $392.7 million in 2024, then dropped by 27.26% to $285.6 million in 2025, then fell by 7.61% to $263.9 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Assets are $263.9 million (Q1 2026), $285.6 million (Q4 2025), and $292.8 million (Q3 2025).